MELA Sciences, Inc. (MELA)
-NasdaqCM 0.83 
0.02(2.20%) 4:00PM EDT|After Hours
:
0.83 0.00 (0.19%) 4:45PM EDT
| Prev Close: | 0.85 |
|---|
| Open: | 0.84 |
|---|
| Bid: | 0.82 x 2000 |
|---|
| Ask: | 0.90 x 3000 |
|---|
| 1y Target Est: | 3.25 |
|---|
| Beta: | -0.07 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 0.81 - 0.85 |
|---|
| 52wk Range: | 0.81 - 4.37 |
|---|
| Volume: | 586,172 |
|---|
| Avg Vol (3m): | 518,931 |
|---|
| Market Cap: | 35.65M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.71 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: MELA Sciences announces Joseph V. Gulfo has resigned as Chairman, President, CEO, and member of the Board of Directors effective June 15, 2013Briefing.com(Mon, Jun 17)
- Joseph V. Gulfo Resigns as CEO of MELA Sciences; Robert C. Coradini Named Interim CEO; David Stone Elected Chairman of the BoardGlobeNewswire(Mon, Jun 17)
- Competitive Advantages, Huge Skin Cancer Market Bode Well For Auraat Seeking Alpha(Wed, Jun 5)
- Finding Investment Opportunities in Quality Growth Health Care Companies That the Rest of the Market is OverlookingWall Street Transcript(Fri, May 17)
- Blue Chips And Investment Trusts Among This Fund's Top Picksat Motley Fool(Fri, May 10)
- Detecting Investment Potential In Medical Diagnostics Companiesat Seeking Alpha(Tue, May 7)
- MELA Sciences, Inc. - Special Callat Seeking Alpha(Mon, May 6)
- Key Energy COO Buys 10K Shares and 4 Insider Trades to Noteat Wall St. Cheat Sheet(Mon, May 6)
- MELA Sciences, Inc. Rings NASDAQ Opening Bell With Leading Dermatologists To Raise Awareness For Melanoma Detection And PreventionPR Newswire(Mon, May 6)
- MELA SCIENCES, INC. /NY FinancialsEDGAR Online Financials(Sat, May 4)
- MELA Sciences, Inc. [MELA] to Ring The NASDAQ Stock Market Opening BellGlobeNewswire(Fri, May 3)
- MELA Sciences' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 1)
- MELA Sciences Announces First Quarter 2013 Financial ResultsGlobeNewswire(Tue, Apr 30)
- MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EEDGAR Online(Tue, Apr 30)
- Q1 2013 MELA Sciences Earnings Release - After Market CloseCCBN(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 88.62 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.72 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.17 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | -0.05 |
|---|
Business Summary
MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma.
View More